Abstract

Degenerative intervertebral disc (IVD) disease, which cannot be completely treated with open or minimally invasive surgery, is primarily caused by nucleus pulposus (NP) degeneration. Meanwhile, NP regeneration requires the intricate coordination of stem cells, growth factors, and biomaterials. The current study sought to develop a regenerative approach for IVD degeneration. To this end, we used a lentiviral vector to introduce the transforming growth factor-β3 (TGF-β3) gene into NP mesenchymal stem cells (NPMSCs) to construct genetically modified seed cells. In addition, bicomponent gelatin methacrylate/hyaluronic acid methacrylate (GH) hydrogels were synthesized based on gelatin methacrylate (GelMA) and hyaluronic acid methacrylate (HAMA) precursors as carriers for TGF-β3-NPMSCs delivery. In vitro differentiation of the loaded stem cells into NP-like structures was improved by the hydrogels' superior mechanical and cytocompatibility features. Moreover, the stem cell-loaded GH hydrogel was delivered to NP tissue via a minimally invasive approach to construct an injectable “transgenic cell-hydrogel” in situ microenvironment, which attenuated IVD degeneration, preserved the integrity of the NP tissue, and sped up extracellular matrix synthesis in a rat model. Collectively, the results of this study demonstrate the potential of this novel therapeutic strategy as an effective regenerative approach for IVD degeneration.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.